Aurora Cannabis | ACB - Sales Revenues

Stock Price
4.69
Daily Change
-0.13 -2.60%
Monthly
-2.19%
Yearly
-14.82%
Q2 Forecast
4.67

Aurora Cannabis reported CAD94.19M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Altria USD 5.08B 170M Dec/2025
ANI Pharmaceuticals USD 247.06M 19.25M Dec/2025
Assertio Holdings USD 29.2M 1.92M Sep/2024
Boston Beer USD 385.7M 151.8M Dec/2025
British American Tobacco GBP 13.5B 1.43B Dec/2025
Canopy Growth CAD 74.54M 7.86M Dec/2025
Constellation Brands USD 2.22B 258.2M Sep/2025
Cronos Group USD 58.39M 22.05M Dec/2025
Imperial Brands GBP 17.57B 8.91B Sep/2025
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Molson Coors Brewing USD 2.66B 310M Dec/2025
Nektar Therapeutics USD 21.81M 2.32M Dec/2025
Organigram Holdings CAD 63.54M 16.52M Dec/2025
Philip Morris International USD 10.4B 400M Dec/2025
Tilray USD 217.51M 74.75M Dec/2025